Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Eton Pharmaceuticals (ETON) Accumulated Depreciation & Amortization (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Accumulated Depreciation & Amortization for 7 consecutive years, with $486000.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 8.97% to $486000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $486000.0 through Dec 2025, up 8.97% year-over-year, with the annual reading at $486000.0 for FY2025, 8.97% up from the prior year.
  • Accumulated Depreciation & Amortization hit $486000.0 in Q4 2025 for Eton Pharmaceuticals, up from $446000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $486000.0 in Q4 2025 to a low of $14000.0 in Q3 2022.
  • Historically, Accumulated Depreciation & Amortization has averaged $247411.8 across 5 years, with a median of $365000.0 in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: plummeted 96.03% in 2021 and later soared 2635.71% in 2023.
  • Year by year, Accumulated Depreciation & Amortization stood at $155000.0 in 2021, then crashed by 57.42% to $66000.0 in 2022, then skyrocketed by 498.48% to $395000.0 in 2023, then rose by 12.91% to $446000.0 in 2024, then increased by 8.97% to $486000.0 in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for ETON at $486000.0 in Q4 2025, $446000.0 in Q4 2024, and $434000.0 in Q3 2024.